You just read:

CureVac Announces Publication in The Lancet of First-Ever Human Proof-of-Concept Study Investigating the Safety and Immunogenicity of a Prophylactic mRNA Vaccine

News provided by

CureVac AG

Jul 26, 2017, 07:03 ET